Dual treatments co-targeting TIGIT and PD-L1 have been proposed in recent literature in the context of colorectal cancer and lung squamous cell carcinoma.44,45 We examined NK cell activation status in co-cultures of MB cells with primary NK cells from healthy donors. This evidence concerns the gene TIGIT and squamous cell lung carcinoma.